In Vitro Toxicology Testing: Tech Trends & Report

In Vitro Toxicology Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global In-vitro Toxicology Testing Market is segmented By Product &amp; Service Type (Assays, Consumables, Services, Equipment&rsquo;s, Software) By Toxicity (Cytotoxicity, Gene Toxicity, Cardiotoxicity, Hepatotoxicity, Ophthalmic Toxicity, Others) By Technology (Cell Culture, High Throughput Screening, Toxicogenomics) By End User (Pharmaceutical and Biopharmaceutical Companies, Consumer Care and Food Industry, Others)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global In-vitro Toxicology Testing Market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing with a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

In vitro models play an important role in the toxicity testing of cosmetics, drugs and pharmaceutical therapies. Advancements in in vitro cell culture have given researchers a viable alternative and/or complement to live animal testing.&nbsp;

In vitro models offer several ethical and economic advantages over animal testing. These assays are being used earlier in toxicity testing pipelines, often to determine risk assessment and/or set up controls that will ultimately spare animal life. The combination of lower-cost and higher throughput assays can help bring products to market faster. Additionally, in vitro models give researchers an advantage in understanding the biological process involved in a toxic response sooner than if they were depending on the visual inspection of a live animal.&nbsp;

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product &amp; Service Type, Toxicity, Technology, End User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on&nbsp;this&nbsp;report&nbsp;- <a href="https://www.datamintelligence.com/download-sample/in-vitro-toxicology-testing-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers and Restraints</h3>

Rise in advancements in in-vitro toxicology testing

Technological advancements in in-vitro toxicology testing have made it a preferred method over animal testing. Regulatory agencies are increasingly validating and accepting these methods, boosting the market. In some countries, animal geno-toxicology testing is mandated before marketing certain consumer items, such as genetically modified foods, vaccines, devices, drugs, industrial chemicals, and pesticides.

Additionally, recent advancements in the understanding of stem cell-derived cardiomyocytes have allowed researchers to develop more accurate and reproducible in vitro assays that are based on human cells. Future work in this area hopes to use stem cell-derived cardiomyocytes that have been integrated into three-dimensional structures for an additional layer of drug safety screening.

Furthermore, the in-vitro toxicology testing market is also driven by various other factors like the rise in demand for healthcare services, rise in the government initiatives and others that help the market to grow during the forecast period.

Restraint

In vitro toxicity testing is gaining recognition due to animal testing bans in several countries. However, it still needs to demonstrate validity compared to in vivo tests. In vitro tests only determine the mechanism of action of test substances, not their outcomes after metabolism. Although a chemical substance may not be harmful, its metabolites can be detrimental.

<h3>Segment Analysis</h3>

The global in-vitro toxicology testing market is segmented based on product and service type, toxicity, technology, end-user and region.

The assays&nbsp; from the product and service type segment accounted for approximately 39.7% of the in-vitro toxicology testing market share

The assays from the product and service type segment accounted for approximately 39.7% and are expected to dominate during the forecast period. In vitro toxicity assays are some of the most useful preclinical methods of not only determining a drug&rsquo;s safety profile but also providing an opportunity for researchers to improve its properties before reaching clinical trials.

In vitro toxicology assays, in silico and chemical testing approaches, are crucial in identifying alternative methods to traditional animal-based toxicity testing. These services support metabolic, toxicokinetic, and bioanalytical investigations with qualitative and quantitative data, promoting the 3Rs (Replacement, Reduction, and Refinement) approach.

<h3>Geographical Analysis</h3>

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the factors like acquisitions by companies, rising government funding for research of therapeutics, increased healthcare expenditure, advanced infrastructure &amp; processes for drug discovery and strong regulatory framework for approval has increased the demand as well as adoption on in-vitro testing methods in this region&rsquo;s market.&nbsp;

For instance, in March 2023, Agilent Technologies, Inc. (US) acquired e-MSion (US). Through this acquisition, Agilent will integrate the e-MSion&#39;s ExD cell into its portfolio of advanced workflows, instruments, and analytical solutions for biotherapeutic characterization and development.

Moreover, in September 2022, ioIVT disclosed the successful acquisition of XenoTech, showcasing its dedication to offering extensive research models and services to biopharmaceutical customers for improved drug development and diagnostic research.

<h3>COVID-19 Impact Analysis</h3>

The COVID-19 pandemic had a substantial impact on the overall market resulting in limitations of movement and restrictions due to which the market observed a short-term decline in growth. However, as there were multiple drug discovery processes, various drug development programs &amp; and high research activities, the market demand for in-vitro toxicology testing accelerated eventually.&nbsp;

<h3>Competitive Landscape</h3>

The major global players in the market include Charles River Laboratories International, Inc., SGS S.A., Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec S.E., Agilent Technologies, Inc., Catalent, Inc., Bio-Rad Laboratories, Inc., BioIVT, Gentronix and among others.

<h3>Key Developments</h3>

<ul>
	<li>In January 2023, Eurofins Scientific expanded its presence in India with the establishment of a new, fully equipped, state-of-the-art laboratory campus in Genome Valley, Hyderabad. The lab will support pharma and biotech companies in the areas of synthetic organic chemistry, analytical R&amp;D, bioanalytical services, in vivo pharmacology, safety toxicology, and formulation R&amp;D.</li>
	<li>In January 2021, Charles River stated a partnership with Cypre, Inc., for the expansion of services of 3D in-vitro models for immunotherapy treatment of cancer as well as targeted therapy drug screening. This partnership enabled the company to access Cypre&rsquo;s patented 3D hydrogel technology or Falcon-X to expand Charles River&rsquo;s services.&nbsp;</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global in-vitro toxicology testing market segmentation based on product and service type, toxicity, technology, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of in-vitro toxicology testing market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global in-vitro toxicology testing market report would provide approximately 69 tables, 70 figures and 183 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product and Service Type</li>
		<li>Snippet by Toxicity</li>
		<li>Snippet by Technology</li>
		<li>Snippet by End User&nbsp;</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Market Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers&nbsp;
			<ol>
				<li>Rise in advancements in in-vitro toxicology testing</li>
				<li>Rise in the government initiatives</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Regulatory Challenges</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers&#39; Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product and Service Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type&nbsp;</li>
			<li>Market Attractiveness Index, By Product and Service Type</li>
		</ol>
		</li>
		<li>Assays *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Consumables</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Equipment</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Services</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Software&nbsp;</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Toxicity</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Toxicity</li>
			<li>Market Attractiveness Index, By Toxicity</li>
		</ol>
		</li>
		<li>Cytotoxicity *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Gene Toxicity</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Cardiotoxicity</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Hepatotoxicity</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Ophthalmic Toxicity</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others&nbsp;</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Technology</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology</li>
		</ol>
		</li>
		<li>Cell Culture*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>High Throughput Screening</li>
		<li>Toxicogenomics</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Attractiveness Index, By End User</li>
		</ol>
		</li>
		<li>Pharmaceutical and Biopharmaceutical Companies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Consumer Care and Food Industry</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Toxicity</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>The U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Toxicity</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Toxicity</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Toxicity</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Toxicity</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Charles River Laboratories International, Inc.*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>SGS S.A.</li>
		<li>Eurofins Scientific</li>
		<li>Laboratory Corporation of America Holdings</li>
		<li>Evotec S.E.</li>
		<li>Agilent Technologies, Inc.</li>
		<li>Catalent, Inc.</li>
		<li>Bio-Rad Laboratories, Inc.</li>
		<li>BioIVT</li>
		<li>Gentronix&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2023, 2027 &amp; 2031(US$ Million)

Table 2 Global In-vitro Toxicology Testing Market Value, By Toxicity, 2023, 2027 &amp; 2031(US$ Million)

Table 3 Global In-vitro Toxicology Testing Market Value, By Technology, 2023, 2027 &amp; 2031(US$ Million)

Table 4 Global In-vitro Toxicology Testing Market Value, By End User, 2023, 2027 &amp; 2031(US$ Million)

Table 5 Global In-vitro Toxicology Testing Market Value, By Region, 2023, 2027 &amp; 2031(US$ Million)

Table 6 Global In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2023, 2027 &amp; 2031(US$ Million)

Table 7 Global In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2022-2031(US$ Million)

Table 8 Global In-vitro Toxicology Testing Market Value, By Toxicity, 2023, 2027 &amp; 2031(US$ Million)

Table 9 Global In-vitro Toxicology Testing Market Value, By Toxicity, 2022-2031(US$ Million)

Table 10 Global In-vitro Toxicology Testing Market Value, By Technology, 2023, 2027 &amp; 2031(US$ Million)

Table 11 Global In-vitro Toxicology Testing Market Value, By Technology, 2022-2031(US$ Million)

Table 12 Global In-vitro Toxicology Testing Market Value, By End User, 2023, 2027 &amp; 2031(US$ Million)

Table 13 Global In-vitro Toxicology Testing Market Value, By End User, 2022-2031(US$ Million)

Table 14 Global In-vitro Toxicology Testing Market Value, By Region, 2023, 2027 &amp; 2031(US$ Million)

Table 15 Global In-vitro Toxicology Testing Market Value, By Region, 2022-2031(US$ Million)

Table 16 North America In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2022-2031(US$ Million)

Table 17 North America In-vitro Toxicology Testing Market Value, By Toxicity, 2022-2031(US$ Million)

Table 18 North America In-vitro Toxicology Testing Market Value, By Technology, 2022-2031(US$ Million)

Table 19 North America In-vitro Toxicology Testing Market Value, By End User, 2022-2031(US$ Million)

Table 20 North America In-vitro Toxicology Testing Market Value, By Country, 2022-2031(US$ Million)

Table 21 South America In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2022-2031(US$ Million)

Table 22 South America In-vitro Toxicology Testing Market Value, By Toxicity, 2022-2031(US$ Million)

Table 23 South America In-vitro Toxicology Testing Market Value, By Technology, 2022-2031(US$ Million)

Table 24 South America In-vitro Toxicology Testing Market Value, By End User, 2022-2031(US$ Million)

Table 25 South America In-vitro Toxicology Testing Market Value, By Country, 2022-2031(US$ Million)

Table 26 Europe In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2022-2031(US$ Million)

Table 27 Europe In-vitro Toxicology Testing Market Value, By Toxicity, 2022-2031(US$ Million)

Table 28 Europe In-vitro Toxicology Testing Market Value, By Technology, 2022-2031(US$ Million)

Table 29 Europe In-vitro Toxicology Testing Market Value, By End User, 2022-2031(US$ Million)

Table 30 Europe In-vitro Toxicology Testing Market Value, By Country, 2022-2031(US$ Million)

Table 31 Asia-Pacific In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2022-2031(US$ Million)

Table 32 Asia-Pacific In-vitro Toxicology Testing Market Value, By Toxicity, 2022-2031(US$ Million)

Table 33 Asia-Pacific In-vitro Toxicology Testing Market Value, By Technology, 2022-2031(US$ Million)

Table 34 Asia-Pacific In-vitro Toxicology Testing Market Value, By End User, 2022-2031(US$ Million)

Table 35 Asia-Pacific In-vitro Toxicology Testing Market Value, By Country, 2022-2031(US$ Million)

Table 36 Middle East &amp; Africa In-vitro Toxicology Testing Market Value, By Product &amp; Service Type, 2022-2031(US$ Million)

Table 37 Middle East &amp; Africa In-vitro Toxicology Testing Market Value, By Toxicity, 2022-2031(US$ Million)

Table 38 Middle East &amp; Africa In-vitro Toxicology Testing Market Value, By Technology, 2022-2031(US$ Million)

Table 39 Middle East &amp; Africa In-vitro Toxicology Testing Market Value, By End User, 2022-2031(US$ Million)

Table 40 Charles River Laboratories International, Inc.: Overview

Table 41 Charles River Laboratories International, Inc.: Product Portfolio

Table 42 Charles River Laboratories International, Inc.: Key Developments

Table 43 SGS S.A.: Overview

Table 44 SGS S.A.: Product Portfolio

Table 45 SGS S.A.: Key Developments

Table 46 Eurofins Scientific: Overview

Table 47 Eurofins Scientific: Product Portfolio

Table 48 Eurofins Scientific: Key Developments

Table 49 Laboratory Corporation of America Holdings: Overview

Table 50 Laboratory Corporation of America Holdings: Product Portfolio

Table 51 Laboratory Corporation of America Holdings: Key Developments

Table 52 Evotec S.E.: Overview

Table 53 Evotec S.E.: Product Portfolio

Table 54 Evotec S.E.: Key Developments

Table 55 Agilent Technologies, Inc.: Overview

Table 56 Agilent Technologies, Inc.: Product Portfolio

Table 57 Agilent Technologies, Inc.: Key Developments

Table 58 Catalent, Inc.: Overview

Table 59 Catalent, Inc.: Product Portfolio

Table 60 Catalent, Inc.: Key Developments

Table 61 Bio-Rad Laboratories, Inc.: Overview

Table 62 Bio-Rad Laboratories, Inc.: Product Portfolio

Table 63 Bio-Rad Laboratories, Inc.: Key Developments

Table 64 BioIVT: Overview

Table 65 BioIVT: Product Portfolio

Table 66 BioIVT: Key Developments

Table 67 Gentronix: Overview

Table 68 Gentronix: Product Portfolio

Table 69 Gentronix: Key Developments&nbsp;

&nbsp;

List of Figures

Figure 1 Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 2 Global In-vitro Toxicology Testing Market Share, By Product &amp; Service Type, 2022-2031 (%)

Figure 3 Global In-vitro Toxicology Testing Market Share, By Toxicity, 2022-2031 (%)

Figure 4 Global In-vitro Toxicology Testing Market Share, By Technology, 2022-2031 (%)

Figure 5 Global In-vitro Toxicology Testing Market Share, By End User, 2022-2031 (%)

Figure 6 Global In-vitro Toxicology Testing Market Share, By Region, 2022-2031 (%)

Figure 7 Global In-vitro Toxicology Testing Market Y-o-Y Growth, By Product &amp; Service Type, 2022-2031 (%)

Figure 8 Assays In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 9 Consumables In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 10 Equipments In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 11 Services In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 12 Software In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 13 Global In-vitro Toxicology Testing Market Y-o-Y Growth, By Toxicity, 2022-2031 (%)

Figure 14 Cytotoxicity Toxicity in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 15 Gene Toxicity Toxicity in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 16 Cardiotoxicity Toxicity in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 17 Hepatotoxicity Toxicity in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 18 Ophthalmic Toxicity Toxicity in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 19 Others Toxicity in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 20 Global In-vitro Toxicology Testing Market Y-o-Y Growth, By Technology, 2022-2031 (%)

Figure 21 Cell Culture Technology in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 22 High Throughput Screening Technology in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 23 Toxicogenomics Technology in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 24 Global In-vitro Toxicology Testing Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 25 Pharmaceutical and Biopharmaceutical Companies End User in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 26 Consumer Care and Food Industry End User in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 27 Others End User in Global In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 28 Global In-vitro Toxicology Testing Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 29 North America In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 30 Asia-Pacific In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 31 Europe In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 32 South America In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 33 Middle East and Africa In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 34 North America In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 35 North America In-vitro Toxicology Testing Market Share, By Product &amp; Service Type, 2022-2031 (%)

Figure 36 North America In-vitro Toxicology Testing Market Share, By Toxicity, 2022-2031 (%)

Figure 37 North America In-vitro Toxicology Testing Market Share, By Technology, 2022-2031 (%)

Figure 38 North America In-vitro Toxicology Testing Market Share, By End User, 2022-2031 (%)

Figure 39 North America In-vitro Toxicology Testing Market Share, By Country, 2022-2031 (%)

Figure 40 South America In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 41 South America In-vitro Toxicology Testing Market Share, By Product &amp; Service Type, 2022-2031 (%)

Figure 42 South America In-vitro Toxicology Testing Market Share, By Toxicity, 2022-2031 (%)

Figure 43 South America In-vitro Toxicology Testing Market Share, By Technology, 2022-2031 (%)

Figure 44 South America In-vitro Toxicology Testing Market Share, By End User, 2022-2031 (%)

Figure 45 South America In-vitro Toxicology Testing Market Share, By Country, 2022-2031 (%)

Figure 46 Europe In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 47 Europe In-vitro Toxicology Testing Market Share, By Product &amp; Service Type, 2022-2031 (%)

Figure 48 Europe In-vitro Toxicology Testing Market Share, By Toxicity, 2022-2031 (%)

Figure 49 Europe In-vitro Toxicology Testing Market Share, By Technology, 2022-2031 (%)

Figure 50 Europe In-vitro Toxicology Testing Market Share, By End User, 2022-2031 (%)

Figure 51 Europe In-vitro Toxicology Testing Market Share, By Country, 2022-2031 (%)

Figure 52 Asia-Pacific In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 53 Asia-Pacific In-vitro Toxicology Testing Market Share, By Product &amp; Service Type, 2022-2031 (%)

Figure 54 Asia-Pacific In-vitro Toxicology Testing Market Share, By Toxicity, 2022-2031 (%)

Figure 55 Asia-Pacific In-vitro Toxicology Testing Market Share, By Technology, 2022-2031 (%)

Figure 56 Asia-Pacific In-vitro Toxicology Testing Market Share, By End User, 2022-2031 (%)

Figure 57 Asia-Pacific In-vitro Toxicology Testing Market Share, By Country, 2022-2031 (%)

Figure 58 Middle East &amp; Africa In-vitro Toxicology Testing Market Value, 2022-2031(US$ Million)

Figure 59 Middle East &amp; Africa In-vitro Toxicology Testing Market Share, By Product &amp; Service Type, 2022-2031 (%)

Figure 60 Middle East &amp; Africa In-vitro Toxicology Testing Market Share, By Toxicity, 2022-2031 (%)

Figure 61 Middle East &amp; Africa In-vitro Toxicology Testing Market Share, By Technology, 2022-2031 (%)

Figure 62 Middle East &amp; Africa In-vitro Toxicology Testing Market Share, By End User, 2022-2031 (%)

Figure 63 Charles River Laboratories International, Inc.: Financials

Figure 64 SGS S.A.: Financials

Figure 65 Eurofins Scientific: Financials

Figure 66 Laboratory Corporation of America Holdings: Financials

Figure 67 Evotec S.E.: Financials

Figure 68 Agilent Technologies, Inc.: Financials

Figure 69 Catalent, Inc.: Financials

Figure 70 Bio-Rad Laboratories, Inc.: Financials

Figure 71 BioIVT: Financials

Figure 72 Gentronix: Financials

In Vitro Toxicology Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

In Vitro Toxicity Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 August 08

Starting from

In Vitro Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 July 21

Starting from

Early Toxicity Testing Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 07

Starting from

Hemato Oncology Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 April 30

Starting from

Hematology Testing Products Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 01

Starting from